If April was the month Americans hunkered down at home to fight the coronavirus pandemic, June may prove the month they officially lost patience, venturing back to restaurants, beauty salons and other socially dense activities that hinted at an economic rebound but may also be contributing to a new...
The United States on Thursday targeted Iran with another round of sanctions on eight firms, this time targeting steel and other metal companies, according to a notice posted on the U.S. Department of Treasury's website.
The Indian arm of consumer giant Unilever said Thursday it will rename its locally marketed "Fair & Lovely" skin-lightening cream in the face of global anti-racism protests.
Sanofi is considering cutting hundreds of jobs and will discuss potential steps with staff representatives over the coming days, four sources said on Thursday, the latest move by the French drugmaker's chief executive Paul Hudson to cut costs.
Occidental Petroleum Corp said on Thursday it expects to take impairment charges of up to US$9 billion in the second quarter related to the value of its assets as the oil producer forecast crude price to remain lower for a long period of time.
Blackstone Group Inc said on Thursday Alphabet Inc's finance chief, Ruth Porat, will join the private equity firm's board of directors.
Markets for stocks and other risky assets could suffer a second swoon if the coronavirus spreads more widely, lockdowns are reimposed or trade tensions surge again, the International Monetary Fund warned on Thursday.
Shares of Walt Disney Co dropped 2.4per cent on Thursday after the media company delayed the reopening of theme parks and resort hotels in California, following a surge in fresh COVID-19 cases in the state.
Turkey's potential ejection from MSCI's widely followed emerging markets index could suck almost a billion dollars out of its stock markets, dealing another blow to the country, whose position is already waning on global markets.
Moderna Inc said on Thursday it has partnered with contract drugmaker Catalent Inc to produce 100 million doses of its experimental COVID-19 vaccine starting in the third quarter of 2020.
